Condition

Small Intestine Cancer

ClinicalTrials.gov condition label

Clinical trials16
Recruiting1
Common interventions25
Lead sponsors shown12

Clinical trials

16 shown
Integrated Cancer Repository for Cancer ResearchNCT02012699 · 2013-11-01
RECRUITING
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNCT06582849 · 2024-10-04
COMPLETED
GI Organ Tracking Via Balloon ApplicatorsNCT05471401 · 2023-04-25
WITHDRAWN
Project HERO: Health Empowerment & Recovery OutcomesNCT03345563 · 2017-07-31
COMPLETED
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerNCT00836992 · 2009-01-01
COMPLETED
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaNCT00734890 · 2008-03-01
COMPLETED
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNCT00896467 · 2007-09-01
TERMINATED
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerNCT00445965 · 2006-01-01
COMPLETED
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaNCT00562380 · 2005-10-01
COMPLETED
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerNCT00036790 · 2002-02-01
COMPLETED
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyNCT00005634 · 2000-01-01
COMPLETED
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaNCT00005590 · 1999-08-01
COMPLETED
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyNCT00003600 · 1998-12-01
COMPLETED
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNCT00019513 · 1998-08-01
COMPLETED
Flavopiridol in Treating Patients With Refractory CancerNCT00019344 · 1997-08-01
COMPLETED
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasNCT00019019 · 1994-10-01
COMPLETED

Common interventions

pharmacological studyOTHER3laboratory biomarker analysisOTHER2131I-3F8RADIATION1alvocidibDRUG1Balloon-tipped catheterDEVICE1bevacizumabBIOLOGICAL1biopsyPROCEDURE1Body Mind Training (BMT)BEHAVIORAL1Body Training (BT):BEHAVIORAL1carboxyamidotriazoleDRUG1DNA analysisGENETIC1doxorubicin hydrochlorideDRUG1Enhanced assistanceOTHER1epoetin alfaBIOLOGICAL1fluorouracilDRUG1ganitumabBIOLOGICAL1gemcitabine hydrochlorideDRUG1immunologic techniqueOTHER1iodine I 131 monoclonal antibody 3F8RADIATION1leucovorin calciumDRUG1levofloxacinDRUG1motexafin gadoliniumDRUG1paclitaxelDRUG1placeboOTHER1psychosocial assessment and carePROCEDURE1

Trial status mix

COMPLETED13
RECRUITING1
TERMINATED1
WITHDRAWN1

Phase mix

PHASE17
NA3
PHASE32
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.